Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 3/20 | 0.54 |
| ▸ | MAPK14 | Q16539 | 7/20 | 0.53 |
| ▸ | MAPK13 | O15264 | 6/20 | 0.53 |
| ▸ | MAPK12 | P53778 | 6/20 | 0.53 |
| ▸ | MAPK11 | Q15759 | 6/20 | 0.53 |
| ▸ | GCGR | P47871 | 1/20 | 0.46 |
| ▸ | GSK3A | P49840 | 4/20 | 0.46 |
| ▸ | GSK3B | P49841 | 4/20 | 0.46 |
| ▸ | CDK2 | P24941 | 2/20 | 0.46 |
| ▸ | JAK2 | O60674 | 1/20 | 0.46 |
| ▸ | PIM1 | P11309 | 1/20 | 0.46 |
| ▸ | TYK2 | P29597 | 1/20 | 0.46 |
| ▸ | SYK | P43405 | 1/20 | 0.46 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.46 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.46 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.46 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.44 |
| ▸ | KCNH3 | Q9ULD8 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7211879 | 0.91 | PTGS2 (0.60) | PTGS2MAPK14MAPK13MAPK12MAPK11 | |
| SCHEMBL27504074 | 0.81 | PTGS2 (0.54) | PTGS2MAPK14MAPK13MAPK12MAPK11 | |
| SCHEMBL7471698 | 0.81 | MEN1 (0.48) | JAK2TYK2NPC1RAB9AKDM4E | |
| SCHEMBL7215273 | 0.81 | PTGS2 (0.53) | PTGS2MAPK14MAPK13MAPK12MAPK11 | |
| SCHEMBL7210164 | 0.80 | PTGS2 (0.49) | PTGS2MAPK14MAPK13MAPK12MAPK11 | |
| SCHEMBL7216156 | 0.78 | PTGS2 (0.59) | PTGS2MAPK14MAPK13MAPK12MAPK11 | |
| SCHEMBL7210237 | 0.78 | MAPK13 (0.50) | PTGS2MAPK14MAPK13MAPK12MAPK11 | |
| SCHEMBL7210156 | 0.77 | PTGS2 (0.51) | PTGS2MAPK14MAPK13MAPK12MAPK11 | |
| SCHEMBL7212196 | 0.76 | MERTK (0.51) | PTGS2MAPK14MAPK13MAPK12MAPK11 | |
| SCHEMBL7215223 | 0.75 | PTGS2 (0.71) | PTGS2MAPK14MAPK13MAPK12MAPK11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6610698-B2 | Treatment of tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6, and interleukin-8 mediated diseases | AMGEN, INC. | 2003-08-26 | — | — | US | disclosed |
| EP-1314732-A2 | Substituted pyrimidine compounds and their use | AMGEN INC. (US) | 2003-05-28 | — | — | EP | disclosed |
| EP-1314731-A2 | Substituted pyrimidine compounds and their use | AMGEN INC. (US) | 2003-05-28 | — | — | EP | disclosed |
| US-6410729-B1 | ANALGESICS; ANTIDIABETIC AGENTS; ANTIINFLAMMATORY AGENTS | AMGEN INC. | 2002-06-25 | — | — | US | disclosed |
| CN-1246858-A | Substituted pyrimidine compounds and their use | AMGEN INC (US) | 2000-03-08 | — | — | CN | disclosed |
| EP-0948497-A2 | SUBSTITUTED PYRIMIDINE COMPOUNDS AND THEIR USE | Amgen inc. (US) | 1999-10-13 | — | — | EP | disclosed |
| WO-1998024782-A2 | SUBSTITUTED PYRIMIDINE COMPOUNDS AND THEIR USE | AMGEN INC. (US) | 1998-06-11 | — | — | WO | disclosed |